Central Nervous System Disease in Patients With RET Fusion-Positive NSCLC Treated With Selpercatinib

Murciano-Goroff, YR; Falcon, CJ; Lin, ST; Chacko, C; Grimaldi, G; Liu, DZ; Wilhelm, C; Iasonos, A; Drilon, A

Drilon, A (通讯作者),Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA.

JOURNAL OF THORACIC ONCOLOGY, 2023; 18 (5): 620

Abstract

Introduction: Central nervous system (CNS) metastases develop in nearly half of patients with RET fusion-positive NSCLCs and cause morbidity and morta......

Full Text Link